论文部分内容阅读
目的:探讨硝普钠在治疗扩张型心肌病的作用。方法:选择扩张型心肌病患者120例,随机平分为治疗组与对照组各60例,两组患者入院后均给予常规治疗,在此基础上治疗组给予硝普钠治疗。结果:经过治疗后,治疗组总有效率为95.0%;对照组总有效率为75.0%,两组相比有统计学差异(P<0.05)。经过超声检测,治疗后治疗组的LVEF值明显高于对照组(P<0.05),LVDd两组对比无明显差异(P>0.05)。结论:硝普钠治疗扩张型心肌病能有效提高治疗效果,改善左室射血分数,值得临床推广应用。
Objective: To investigate the role of sodium nitroprusside in the treatment of dilated cardiomyopathy. Methods: 120 patients with dilated cardiomyopathy were randomly divided into treatment group and control group, with 60 cases in each group. Both groups were given routine treatment after admission. On the basis of this, the treatment group was treated with sodium nitroprusside. Results: After treatment, the total effective rate was 95.0% in the treatment group and 75.0% in the control group. There was significant difference between the two groups (P <0.05). After ultrasonic testing, the LVEF of the treatment group was significantly higher than that of the control group (P <0.05). There was no significant difference between the two groups (P> 0.05). Conclusion: Sodium nitroprusside treatment of dilated cardiomyopathy can effectively improve the therapeutic effect and improve left ventricular ejection fraction, which is worthy of clinical application.